Standout Papers

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge 2022 2026 2023 2024184
  1. Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge (2022)
    Ronen Arbel, Yael Wolff Sagy et al. New England Journal of Medicine
  2. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study (2023)
    Ronen Arbel, Alon Peretz et al. The Lancet Infectious Diseases
  3. Real-world effectiveness of a single dose of mpox vaccine in males (2023)
    Yael Wolff Sagy, Ariel Hammerman et al. Nature Medicine

Immediate Impact

2 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Long COVID science, research and policy
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
2 intermediate papers

Works of Ariel Hammerman being referenced

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge
2022 Standout

Author Peers

Author Last Decade Papers Cites
Ariel Hammerman 154 118 91 335 198 63 1.1k
Diane Potvin 69 178 180 106 73 40 1.1k
Glenn Davies 199 131 416 247 203 37 1.1k
Andrew J. Innes 33 55 154 164 123 82 1.3k
J Oyee 108 51 42 110 58 35 860
Blanca Lumbreras 72 55 193 88 169 98 1.3k
June‐Ho Kim 72 41 45 114 130 28 933
Ruth Smith 35 53 91 517 423 22 1.2k
M. A. Mangues 88 47 96 71 92 48 959
Giorgio Lorenzo Colombo 143 67 85 127 370 71 1.0k
Weili He 159 48 91 542 651 50 1.3k

All Works

Loading papers...

Rankless by CCL
2026